Auto Disable Syringes Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)

Description

In-Depth Analysis of Market Dynamics

The comprehensive report on the global auto disable syringes market provides a deep understanding of this vital industry. With critical insights aimed at guiding stakeholders, healthcare providers, and manufacturers, the report offers informed strategies and growth opportunities.

Key Insights from the Report:

Market Valuation: The global auto disable syringes market is estimated to be approximately US$20 billion.

Leading Application Segment: Immunization leads in demand, accounting for the largest market share.

Key Role of Institutions: Governments and non-governmental institutions play a critical role in initiating immunization drives.

Market Constraints: Limited affordability and accessibility pose long-term challenges to market expansion.

Rapid Growth in Asia Pacific: The Asia Pacific region is projected to exhibit significant market growth.

Prominent Industry Players: Becton, Dickinson and Company, Terumo Corporation, and Hindustan Syringes & Medical Devices Limited are key players in the market.

Market Overview

The global auto disable syringes market focuses on the development, manufacturing, and distribution of single-use syringes to minimize the risks of reuse and infection transmission. With a projected robust growth outlook, this market is driven by the rise in immunization initiatives and increased awareness about infection prevention. These factors contribute to the growing demand for auto disable syringes, crucial for safe and hygienic medical procedures. The market is on the brink of exponential expansion.

Market Drivers

Global Immunization Programs and Initiatives

The growth of the auto disable syringes market is propelled by global immunization programs supported by organizations like WHO and UNICEF. These programs necessitate safe, effective, and single-use immunization tools, making auto disable syringes the ideal choice. They ensure that each injection is administered with a sterile syringe, reducing contamination risks and infections.

Robust Infection Control Measures

Auto disable syringes find increased demand due to the emphasis on infection control in healthcare settings. They play a vital role in preventing infections through needle-stick injuries or syringe reuse, aligning with infection control guidelines. Healthcare professionals opt for auto disable syringes to create a safe and hygienic environment.

Technological Advancements

Technological progress has driven market growth by enabling the development of efficient, safer, and user-friendly auto disable syringes. Investment in research and development enhances design and functionality, resulting in precise dosing, improved safety features, and greater ease of use. These advancements benefit healthcare providers and enhance patient experience.

Market Challenges

Regulatory Compliance

Diverse regulatory frameworks across countries pose challenges for the global auto disable syringes market. Manufacturers must adhere to varying standards and requirements, adding complexity to manufacturing and distribution processes.

Affordability and Accessibility

The relatively higher cost of auto disable syringes compared to conventional syringes could hinder market growth, especially in resource-limited settings. Addressing affordability is crucial to ensuring wider adoption and accessibility.

Opportunities in Asia Pacific

While North America holds a significant share due to its advanced healthcare system, the Asia-Pacific region is projected to grow rapidly. The region's improving healthcare system, expanding vaccination programs, and heightened awareness of infection prevention drive demand. Major market players are targeting the Asia Pacific region to meet increasing demand for advanced injection safety devices.

Key Market Players - Auto Disable Syringes Landscape

Major players include:

Becton, Dickinson and Company

Terumo Corporation

Hindustan Syringes & Medical Devices Limited

These companies focus on innovation, safety, and user-friendliness, employing strategies like collaborations, acquisitions, and product launches.

Key Company Developments

In 2021, Becton, Dickinson and Company introduced enhanced safety features in their auto disable syringes.

In 2022, Terumo Corporation launched a vaccination-specific auto disable syringe.

In 2023, Hindustan Syringes & Medical Devices Limited expanded manufacturing capacity to meet global demand.

The global auto disable syringes market is poised for remarkable growth. Driven by immunization initiatives, infection control measures, and technological advancements, this market is integral to safe medical practices and infection prevention. Challenges related to regulatory compliance and affordability must be overcome to ensure wider adoption. As the Asia-Pacific region emerges as a lucrative market, industry players are actively exploring opportunities and meeting the demand for advanced injection safety devices.

1. Executive Summary

1.1. Global Auto Disable Syringes Market Outlook, 2018 - 2030 Value (US$ Million) and Volume (Number of Doses) (Million)
1.2. Global Auto Disable Syringes Market Incremental Opportunity, 2018 - 2030 Value (US$ Million) and Volume (Number of Doses) (Million)
1.3. Key Industry Trends

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
  - 2.2.1.1. Driver 1
  - 2.2.1.2. Driver 2
- 2.2.2. Restraints
  - 2.2.2.1. Restraint 1
  - 2.2.2.2. Restraint 2
- 2.2.3. Opportunities
  - 2.2.3.1. Opportunity 1
  - 2.2.3.2. Opportunity 2
2.3. Regulatory Scenario
2.4. Technological Advancements
2.5. Production Capacity of Key Players
2.6. Pricing Analysis
2.7. Global Immunization Program & supply-demand dynamics
2.8. COVID-19 Impact Analysis

3. Global Auto Disable Syringes Market Outlook, 2018 - 2030

3.1. Global Auto Disable Syringes Market Outlook, By Mechanism, 2018 - 2030
- 3.1.1. Key Highlights
- 3.1.2. Global Auto Disable Syringes Market Outlook, By Mechanism, Value (US$ Million) and Volume (million), 2018 - 2030
  - 3.1.2.1. Retractable
    - 3.1.2.1.1. Automatic Retractable
    - 3.1.2.1.2. Manually Retractable
  - 3.1.2.2. Non- Retractable
    - 3.1.2.2.1. Slip
    - 3.1.2.2.2. Lock
    - 3.1.2.2.3. Needle covers
  - 3.1.2.3. Others
- 3.1.3. Global Auto Disable Syringes Market Share and BPS Analysis, By Mechanism, 2021 and 2030
- 3.1.4. Global Auto Disable Syringes Market Attractiveness Analysis, By Mechanism, 2021 - 2030
3.2. Global Auto Disable Syringes Market Outlook, By Capacity, 2018 - 2030
- 3.2.1. Key Highlights
- 3.2.2. Global Auto Disable Syringes Market Outlook, By Capacity, Value (US$ Million) and Volume (million), 2018 - 2030
  - 3.2.2.1. < 0.5 ml
  - 3.2.2.2. 0.5 ml - 1 ml
  - 3.2.2.3. 1 ml <
- 3.2.3. Global Auto Disable Syringes Market Share and BPS Analysis, By Capacity, 2021 and 2030
- 3.2.4. Global Auto Disable Syringes Market Attractiveness Analysis, By Capacity, 2021 - 2030
3.3. Global Auto Disable Syringes Market Outlook, By Application, 2018 - 2030
- 3.3.1. Key Highlights
- 3.3.2. Global Auto Disable Syringes Market Outlook, by Application, Value (US$ Million) and Volume (million), 2018 - 2030
  - 3.3.2.1. Curative
  - 3.3.2.2. Diagnosis
  - 3.3.2.3. Immunization
  - 3.3.2.4. Others
- 3.3.3. Global Auto Disable Syringes Market Share and BPS Analysis, by Application, 2021 and 2030
- 3.3.4. Global Auto Disable Syringes Market Attractiveness Analysis, by Application, 2021 - 2030
3.4. Global Auto Disable Syringes Market Outlook, By End User, 2018 - 2030
- 3.4.1. Key Highlights
- 3.4.2. Global Auto Disable Syringes Market Outlook, by End User, Value (US$ Million) and Volume (million), 2018 - 2030
  - 3.4.2.1. Hospitals & Clinics
  - 3.4.2.2. Diagnostic Laboratories
  - 3.4.2.3. Ambulatory surgical centers
  - 3.4.2.4. Others
- 3.4.3. Global Auto Disable Syringes Market Share and BPS Analysis, by End User, 2021 and 2030
- 3.4.4. Global Auto Disable Syringes Market Attractiveness Analysis, by End User, 2021 - 2030
3.5. Global Auto Disable Syringes Market Outlook, By Region, 2018 - 2030
- 3.5.1. Key Highlights
- 3.5.2. Global Auto Disable Syringes Market Outlook, by Region, Value (US$ Million) and Volume (million), 2018 - 2030
  - 3.5.2.1. North America
  - 3.5.2.2. Europe
  - 3.5.2.3. Asia Pacific
  - 3.5.2.4. Latin America
  - 3.5.2.5. Middle East & Africa
- 3.5.3. Global Auto Disable Syringes Market Share and BPS Analysis, by Region, 2021 and 2030
- 3.5.4. Global Auto Disable Syringes Market Attractiveness Analysis, by Region, 2021 - 2030

4. North America Auto Disable Syringes Market Outlook, 2018 - 2030

4.1. North America Auto Disable Syringes Market Outlook, By Mechanism, 2018 - 2030
- 4.1.1. Key Highlights
- 4.1.2. North America Auto Disable Syringes Market Outlook, By Mechanism, Value (US$ Million) and Volume (million), 2018 - 2030
  - 4.1.2.1. Retractable
    - 4.1.2.1.1. Automatic Retractable
    - 4.1.2.1.2. Manually Retractable
  - 4.1.2.2. Non- Retractable
    - 4.1.2.2.1. Slip
    - 4.1.2.2.2. Lock
    - 4.1.2.2.3. Needle covers
  - 4.1.2.3. Others
- 4.1.3. North America Auto Disable Syringes Market Share and BPS Analysis, By Mechanism, 2021 and 2030
4.2. North America Auto Disable Syringes Market Outlook, By Capacity, 2018 - 2030
- 4.2.1. Key Highlights
- 4.2.2. North America Auto Disable Syringes Market Outlook, By Capacity, Value (US$ Million) and Volume (million), 2018 - 2030
  - 4.2.2.1. < 0.5 ml
  - 4.2.2.2. 0.5 ml - 1 ml
  - 4.2.2.3. 1 ml <
- 4.2.3. North America Auto Disable Syringes Market Share and BPS Analysis, By Capacity, 2021 and 2030
4.3. North America Auto Disable Syringes Market Outlook, By Application, 2018 - 2030
- 4.3.1. Key Highlights
- 4.3.2. North America Auto Disable Syringes Market Outlook, by Application, Value (US$ Million) and Volume (million), 2018 - 2030
  - 4.3.2.1. Curative
  - 4.3.2.2. Diagnosis
  - 4.3.2.3. Immunization
  - 4.3.2.4. Others
- 4.3.3. North America Auto Disable Syringes Market Share and BPS Analysis, by Application, 2021 and 2030
4.4. North America Auto Disable Syringes Market Outlook, By End User, 2018 - 2030
- 4.4.1. Key Highlights
- 4.4.2. North America Auto Disable Syringes Market Outlook, by End User, Value (US$ Million) and Volume (million), 2018 - 2030
  - 4.4.2.1. Hospitals & Clinics
  - 4.4.2.2. Diagnostic Laboratories
  - 4.4.2.3. Ambulatory surgical centers
  - 4.4.2.4. Others
- 4.4.3. North America Auto Disable Syringes Market Share and BPS Analysis, by End User, 2021 and 2030
4.5. North America Auto Disable Syringes Market Outlook, By Country, 2018 - 2030
- 4.5.1. Key Highlights
- 4.5.2. North America Market Outlook, by Country, Value (US$ Million) and Volume (million), 2018 - 2030
  - 4.5.2.1. U.S.
  - 4.5.2.2. Canada
- 4.5.3. North America Auto Disable Syringes Market Share and BPS Analysis, by Country, 2021 and 2030

5. Europe Auto Disable Syringes Market Outlook, 2018 - 2030

5.1. Europe Auto Disable Syringes Market Outlook, By Mechanism, 2018 - 2030
- 5.1.1. Key Highlights
- 5.1.2. Europe Auto Disable Syringes Market Outlook, By Mechanism, Value (US$ Million) and Volume (million), 2018 - 2030
  - 5.1.2.1. Retractable
    - 5.1.2.1.1. Automatic Retractable
    - 5.1.2.1.2. Manually Retractable
  - 5.1.2.2. Non- Retractable
    - 5.1.2.2.1. Slip
    - 5.1.2.2.2. Lock
    - 5.1.2.2.3. Needle covers
  - 5.1.2.3. Others
- 5.1.3. Europe Auto Disable Syringes Market Share and BPS Analysis, By Mechanism, 2021 and 2030
5.2. Europe Auto Disable Syringes Market Outlook, By Capacity, 2018 - 2030
- 5.2.1. Key Highlights
- 5.2.2. Europe Auto Disable Syringes Market Outlook, By Capacity, Value (US$ Million) and Volume (million), 2018 - 2030
  - 5.2.2.1. < 0.5 ml
  - 5.2.2.2. 0.5 ml - 1 ml
  - 5.2.2.3. 1 ml <
- 5.2.3. Europe Auto Disable Syringes Market Share and BPS Analysis, By Capacity, 2021 and 2030
5.3. Europe Auto Disable Syringes Market Outlook, By Application, 2018 - 2030
- 5.3.1. Key Highlights
- 5.3.2. Europe Auto Disable Syringes Market Outlook, by Application, Value (US$ Million) and Volume (million), 2018 - 2030
  - 5.3.2.1. Curative
  - 5.3.2.2. Diagnosis
  - 5.3.2.3. Immunization
  - 5.3.2.4. Others
- 5.3.3. Europe Auto Disable Syringes Market Share and BPS Analysis, by Application, 2021 and 2030
5.4. Europe Auto Disable Syringes Market Outlook, By End User, 2018 - 2030
- 5.4.1. Key Highlights
- 5.4.2. Europe Auto Disable Syringes Market Outlook, by End User, Value (US$ Million) and Volume (million), 2018 - 2030
  - 5.4.2.1. Hospitals & Clinics
  - 5.4.2.2. Diagnostic Laboratories
  - 5.4.2.3. Ambulatory surgical centers
  - 5.4.2.4. Others
- 5.4.3. Europe Auto Disable Syringes Market Share and BPS Analysis, by End User, 2021 and 2030
5.5. Europe Auto Disable Syringes Market Outlook, By Country, 2018 - 2030
- 5.5.1. Key Highlights
- 5.5.2. Europe Auto Disable Syringes Market Outlook, by Country, Value (US$ Million) and Volume (million), 2018 - 2030
  - 5.5.2.1. Germany
  - 5.5.2.2. France
  - 5.5.2.3. U.K.
  - 5.5.2.4. Italy
  - 5.5.2.5. Spain
  - 5.5.2.6. Russia
  - 5.5.2.7. Rest of Europe
- 5.5.3. Europe Auto Disable Syringes Market Share and BPS Analysis, by Country, 2021 and 2030

6. Asia Pacific Auto Disable Syringes Market Outlook, 2018 - 2030

6.1. Asia Pacific Auto Disable Syringes Market Outlook, By Mechanism, 2018 - 2030
- 6.1.1. Key Highlights
- 6.1.2. Asia Pacific Auto Disable Syringes Market Outlook, By Mechanism, Value (US$ Million) and Volume (million), 2018 - 2030
  - 6.1.2.1. Retractable
    - 6.1.2.1.1. Automatic Retractable
    - 6.1.2.1.2. Manually Retractable
  - 6.1.2.2. Non- Retractable
    - 6.1.2.2.1. Slip
    - 6.1.2.2.2. Lock
    - 6.1.2.2.3. Needle covers
  - 6.1.2.3. Others
- 6.1.3. Asia Pacific Auto Disable Syringes Market Share and BPS Analysis, By Mechanism, 2021 and 2030
6.2. Asia Pacific Auto Disable Syringes Market Outlook, By Capacity, 2018 - 2030
- 6.2.1. Key Highlights
- 6.2.2. Asia Pacific Auto Disable Syringes Market Outlook, By Capacity, Value (US$ Million) and Volume (million), 2018 - 2030
  - 6.2.2.1. < 0.5 ml
  - 6.2.2.2. 0.5 ml - 1 ml
  - 6.2.2.3. 1 ml <
- 6.2.3. Asia Pacific Auto Disable Syringes Market Share and BPS Analysis, By Capacity, 2021 and 2030
6.3. Asia Pacific Auto Disable Syringes Market Outlook, By Application, 2018 - 2030
- 6.3.1. Key Highlights
- 6.3.2. Asia Pacific Auto Disable Syringes Market Outlook, by Application, Value (US$ Million) and Volume (million), 2018 - 2030
  - 6.3.2.1. Curative
  - 6.3.2.2. Diagnosis
  - 6.3.2.3. Immunization
  - 6.3.2.4. Others
- 6.3.3. Asia Pacific Auto Disable Syringes Market Share and BPS Analysis, by Application, 2021 and 2030
6.4. Asia Pacific Auto Disable Syringes Market Outlook, By End User, 2018 - 2030
- 6.4.1. Key Highlights
- 6.4.2. Asia Pacific Auto Disable Syringes Market Outlook, by End User, Value (US$ Million) and Volume (million), 2018 - 2030
  - 6.4.2.1. Hospitals & Clinics
  - 6.4.2.2. Diagnostic Laboratories
  - 6.4.2.3. Ambulatory surgical centers
  - 6.4.2.4. Others
- 6.4.3. Asia Pacific Auto Disable Syringes Market Share and BPS Analysis, by End User, 2021 and 2030
6.5. Asia Pacific Auto Disable Syringes Market Outlook, By Country, 2018 - 2030
- 6.5.1. Key Highlights
- 6.5.2. Asia Pacific Auto Disable Syringes Market Outlook, by Country, Value (US$ Million) and Volume (million), 2018 - 2030
  - 6.5.2.1. Japan
  - 6.5.2.2. China
  - 6.5.2.3. India
  - 6.5.2.4. Australia & New Zealand
  - 6.5.2.5. South Korea
  - 6.5.2.6. Rest of Asia Pacific
- 6.5.3. Asia Pacific Auto Disable Syringes Market Share and BPS Analysis, by Country, 2021 and 2030

7. Latin America Auto Disable Syringes Market Outlook, 2018 - 2030

7.1. Latin America Auto Disable Syringes Market Outlook, By Mechanism, 2018 - 2030
- 7.1.1. Key Highlights
- 7.1.2. Latin America Auto Disable Syringes Market Outlook, By Mechanism, Value (US$ Million) and Volume (million), 2018 - 2030
  - 7.1.2.1. Retractable
    - 7.1.2.1.1. Automatic Retractable
    - 7.1.2.1.2. Manually Retractable
  - 7.1.2.2. Non- Retractable
    - 7.1.2.2.1. Slip
    - 7.1.2.2.2. Lock
    - 7.1.2.2.3. Needle covers
  - 7.1.2.3. Others
- 7.1.3. Latin America Auto Disable Syringes Market Share and BPS Analysis, By Mechanism, 2021 and 2030
7.2. Latin America Auto Disable Syringes Market Outlook, By Capacity, 2018 - 2030
- 7.2.1. Key Highlights
- 7.2.2. Latin America Auto Disable Syringes Market Outlook, By Capacity, Value (US$ Million) and Volume (million), 2018 - 2030
  - 7.2.2.1. < 0.5 ml
  - 7.2.2.2. 0.5 ml - 1 ml
  - 7.2.2.3. 1 ml <
- 7.2.3. Latin America Auto Disable Syringes Market Share and BPS Analysis, By Capacity, 2021 and 2030
7.3. Latin America Auto Disable Syringes Market Outlook, By Application, 2018 - 2030
- 7.3.1. Key Highlights
- 7.3.2. Latin America Auto Disable Syringes Market Outlook, by Application, Value (US$ Million) and Volume (million), 2018 - 2030
  - 7.3.2.1. Curative
  - 7.3.2.2. Diagnosis
  - 7.3.2.3. Immunization
  - 7.3.2.4. Others
- 7.3.3. Latin America Auto Disable Syringes Market Share and BPS Analysis, by Application, 2021 and 2030
7.4. Latin America Auto Disable Syringes Market Outlook, By End User, 2018 - 2030
- 7.4.1. Key Highlights
- 7.4.2. Latin America Auto Disable Syringes Market Outlook, by End User, Value (US$ Million) and Volume (million), 2018 - 2030
  - 7.4.2.1. Hospitals & Clinics
  - 7.4.2.2. Diagnostic Laboratories
  - 7.4.2.3. Ambulatory surgical centers
  - 7.4.2.4. Others
- 7.4.3. Latin America Auto Disable Syringes Market Share and BPS Analysis, by End User, 2021 and 2030
7.5. Latin America Auto Disable Syringes Market Outlook, By Country, 2018 - 2030
- 7.5.1. Key Highlights
- 7.5.2. Latin America Auto Disable Syringes Market Outlook, by Country, Value (US$ Million) and Volume (million), 2018 - 2030
  - 7.5.2.1. Brazil
  - 7.5.2.2. Mexico
  - 7.5.2.3. Argentina
  - 7.5.2.4. Rest of Latin America
- 7.5.3. Latin America Auto Disable Syringes Market Share and BPS Analysis, by Country, 2021 and 2030

8. Middle East & Africa Auto Disable Syringes Market Outlook, 2018 - 2030

8.1. Middle East & Africa Auto Disable Syringes Market Outlook, By Mechanism, 2018 - 2030
- 8.1.1. Key Highlights
- 8.1.2. Middle East & Africa Auto Disable Syringes Market Outlook, By Mechanism, Value (US$ Million) and Volume (million), 2018 - 2030
  - 8.1.2.1. Retractable
    - 8.1.2.1.1. Automatic Retractable
    - 8.1.2.1.2. Manually Retractable
  - 8.1.2.2. Non- Retractable
    - 8.1.2.2.1. Slip
    - 8.1.2.2.2. Lock
    - 8.1.2.2.3. Needle covers
  - 8.1.2.3. Others
- 8.1.3. Middle East & Africa Auto Disable Syringes Market Share and BPS Analysis, By Mechanism, 2021 and 2030
8.2. Middle East & Africa Auto Disable Syringes Market Outlook, By Capacity, 2018 - 2030
- 8.2.1. Key Highlights
- 8.2.2. Middle East & Africa Auto Disable Syringes Market Outlook, By Capacity, Value (US$ Million) and Volume (million), 2018 - 2030
  - 8.2.2.1. < 0.5 ml
  - 8.2.2.2. 0.5 ml - 1 ml
  - 8.2.2.3. 1 ml <
- 8.2.3. Middle East & Africa Auto Disable Syringes Market Share and BPS Analysis, By Capacity, 2021 and 2030
8.3. Middle East & Africa Auto Disable Syringes Market Outlook, By Application, 2018 - 2030
- 8.3.1. Key Highlights
- 8.3.2. Middle East & Africa Auto Disable Syringes Market Outlook, by Application, Value (US$ Million) and Volume (million), 2018 - 2030
  - 8.3.2.1. Curative
  - 8.3.2.2. Diagnosis
  - 8.3.2.3. Immunization
  - 8.3.2.4. Others
- 8.3.3. Middle East & Africa Auto Disable Syringes Market Share and BPS Analysis, by Application, 2021 and 2030
8.4. Middle East & Africa Auto Disable Syringes Market Outlook, By End User, 2018 - 2030
- 8.4.1. Key Highlights
- 8.4.2. Middle East & Africa Auto Disable Syringes Market Outlook, by End User, Value (US$ Million) and Volume (million), 2018 - 2030
  - 8.4.2.1. Hospitals & Clinics
  - 8.4.2.2. Diagnostic Laboratories
  - 8.4.2.3. Ambulatory surgical centers
  - 8.4.2.4. Others
- 8.4.3. Middle East & Africa Auto Disable Syringes Market Share and BPS Analysis, by End User, 2021 and 2030
8.5. Middle East & Africa Auto Disable Syringes Market Outlook, By Country, 2018 - 2030
- 8.5.1. Key Highlights
- 8.5.2. Middle East & Africa Auto Disable Syringes Market Outlook, by Country, Value (US$ Million) and Volume (million), 2018 - 2030
  - 8.5.2.1. Saudi Arabia
  - 8.5.2.2. UAE
  - 8.5.2.3. Israel
  - 8.5.2.4. South Africa
  - 8.5.2.5. Rest of Middle East & Africa
- 8.5.3. Middle East & Africa Auto Disable Syringes Market Share and BPS Analysis, by Country, 2021 and 2030

9. Competitive Landscape

9.1. Market Share Analysis, 2020
9.2. Company Profiles
- 9.2.1. B. Braun Melsungen AG
  - 9.2.1.1. Company overview
  - 9.2.1.2. Financial performance
  - 9.2.1.3. Product Pipeline
  - 9.2.1.4. Recent Developments
- 9.2.2. Becton, Dickinson and Company (BD)
- 9.2.3. Cardinal Health
- 9.2.4. Hindustan Syringes & Medical Devices Ltd
- 9.2.5. Nipro
- 9.2.6. Smiths Medical
- 9.2.7. Teleflex Incorporated
- 9.2.8. Terumo Europe NV Appendix

10. Competitive Landscape

10.1. Research Methodology
10.2. Report Specific Research Approach
10.3. Acronyms and Abbreviations